Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Plos One|June 21, 2013
Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse modelClement A Meseda, Joseph Campbell, Arunima Kumar, et al.Biochemical and Biophysical Research Communications|December 3, 2014
Non-coding RNAs and heme oxygenase-1 in vaccinia virus infectionClement A Meseda, Kumar Srinivasan, Jasen Wise, et al.Vaccine|November 6, 2009
Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challengeYong He, Clement A Meseda, Russell A Vassell, et al.Clinical and Vaccine Immunology : CVI|June 29, 2007
Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccinesAlonzo D García, Clement A Meseda, Anne E Mayer, et al.Virology|September 17, 2005
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulinAgnes Jones-Trower, Alonzo Garcia, Clement A Meseda, et al.Scientific Reports|March 31, 2018
Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or NeuraminidaseClement A Meseda, Vajini Atukorale, Jackeline Soto, et al.Antiviral Research|May 13, 2017
Development of an animal model of progressive vaccinia in nu/nu mice and the use of bioluminescence imaging for assessment of the efficacy of monoclonal antibodies against vaccinial B5 and L1 proteinsMarina Zaitseva, Antonia Thomas, Clement A Meseda, et al.The Journal of Infectious Diseases|September 1, 2007
Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunityYong He, Jody Manischewitz, Clement A Meseda, et al.Virology|July 5, 2005
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse modelClement A Meseda, Alonzo D Garcia, Arunima Kumar, et al.NPJ Vaccines|December 4, 2021
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challengeClement A Meseda, Charles B Stauft, Prabhuanand Selvaraj, et al.Pageof 3